Bernard Landry

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Michèle Tameris, Mark Hatherill, Bernard Landry et al. · The Lancet · 2013 · 1K citations · Full text

Public Health, Immunology, Pediatrics +14

Prevention of <i>M. tuberculosis</i> Infection with H4:IC31 Vaccine or BCG Revaccination

Elisa Nemes, Hennie Geldenhuys, Virginie Rozot et al. · New England Journal of Medicine · 2018 · 667 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17

T-cell activation is an immune correlate of risk in BCG vaccinated infants

Helen A. Fletcher, Margaret Ann Snowden, Bernard Landry et al. · Nature Communications · 2016 · 272 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial

B Ndiaye, Friedrich Thienemann, Martin O. C. Ota et al. · The Lancet Respiratory Medicine · 2015 · 163 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study

Jason R. Andrews, Elisa Nemes, Michèle Tameris et al. · The Lancet Respiratory Medicine · 2017 · 149 citations · Full text

Public Health, Infectious Diseases, Pediatrics +17